Toggle light / dark theme

Trigger Alert. — This YT is a deep dive into DNA companies which is fascinating — unfortunately it is anti Israel (or appears to me)

However the background research is good and I think worth a read.

Admin if this crosses any lines-Apologies and please delete.

If one can look past the obvious bias of the author it does have some nuggets of gold.

As a control, other brains received either a fake solution or no solution at all. None revived brain activity and deteriorated as normal.

The researchers hope the technology can enhance our ability to study the brain and its cellular functions. One of the main avenues of such studies would be brain disorders and diseases. This could point the way to developing new of treatments for the likes of brain injuries, Alzheimer’s, Huntington’s, and neurodegenerative conditions.

A medical breakthrough could help millions of Americans see a bit more clearly. In the latest edition of Your Health on TODAY, NBC’s Kristen Dahlgren reports on a new treatment that could replace your reading glasses.

» Watch TODAY All Day: http://www.youtube.com/today.
» Subscribe to TODAY: http://on.today.com/SubscribeToTODAY
» Watch the latest from TODAY: http://bit.ly/LatestTODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY’s Website: http://on.today.com/ReadTODAY
Find TODAY on Facebook: http://on.today.com/LikeTODAY
Follow TODAY on Twitter: http://on.today.com/FollowTODAY
Follow TODAY on Instagram: http://on.today.com/InstaTODAY
Follow TODAY on Pinterest: http://on.today.com/PinTODAY

Fda-approved eyedrops could replace your reading glasses.

This year, an estimated 100,000 people in the U.S. will be diagnosed with melanoma, a rare but aggressive form of skin cancer — and even if they beat it, they’ll be at a high risk of developing melanoma again.

That might not always be the case, though, as a personalized skin cancer vaccine developed from patients’ own tumor cells has shown promise in a very small trial, involving eight melanoma survivors.

“We found evidence of everything we look for in a strong, sustained immune response,” study co-leader Patrick A. Ott said in a press release.

Earlier this month, Airtable announced it’s now worth $11 billion after its latest funding round. The company’s “code-for-everyone-else approach allows professionals who aren’t fluent in coding languages such as Java or Python, and don’t have their desk buried deep within the stack, to play a part in rethinking and remaking the consumer and client digital experience,” reports Riley de León of CNBC. “The low-code movement has attracted an even higher level of attention as a result of the pandemic, during which organizations from hospitals to government entities and corporations have had to develop online offerings at a faster pace than ever expected and for new use cases.”

This movement is part of an increasing democratization of programming — borne of extreme necessity. At a time when digital transformation is everywhere, “relying on IT departments and professional programmers is unsustainable,” an O’Reilly report states. “We need to enable people who aren’t programmers to develop the software they need. We need to enable people to solve their own computational problems.”

Engineers from National University of Singapore (NUS) have built a robotics system they say can grip various objects, ranging from soft and delicate to bulky and heavy. Designed to be configurable, the robotic hand is touted to address the needs of sectors such as vertical farming, food assembly, and fast-moving consumer goods packaging, and with a 23% improvement in efficiency.

These industries increasingly were automating more of their operations, but currently required manual handling for some processes, according to NUS. The human hand’s natural dexterity remained necessary for these tasks.

Rave Yeow, associate professor from NUS Advanced Robotics Centre and Department of Biomedical Engineering, said: “An object’s shape, texture, weight, and size affect how we choose to grip them. This is one of the main reasons why many industries still heavily rely on human labour to package and handle delicate items.”

Cambridge scientists have identified a key signal that the fetus uses to control its supply of nutrients from the placenta, revealing a tug-of-war between genes inherited from the father and from the mother. The study, carried out in mice, could help explain why some babies grow poorly in the womb.

As the fetus grows, it needs to communicate its increasing needs for food to the mother. It receives its nourishment via blood vessels in the placenta, a specialised organ that contains cells from both baby and mother.

Between 10% and 15% of babies grow poorly in the womb, often showing reduced growth of blood vessels in the placenta. In humans, these blood vessels expand dramatically between mid and late gestation, reaching a total length of approximately 320 kilometres at term.